RT Journal Article
SR Electronic
T1 Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003392
DO 10.1136/jitc-2021-003392
VO 10
IS 1
A1 Goswami, Meghali
A1 Gui, Gege
A1 Dillon, Laura W
A1 Lindblad, Katherine E
A1 Thompson, Julie
A1 Valdez, Janet
A1 Kim, Dong-Yun
A1 Ghannam, Jack Y
A1 Oetjen, Karolyn A
A1 Destefano, Christin B
A1 Smith, Dana M
A1 Tekleab, Hanna
A1 Li, Yeusheng
A1 Dagur, Pradeep
A1 Hughes, Thomas
A1 Marté, Jennifer L
A1 del Rivero, Jaydira
A1 Klubo-Gwiezdzinksa, Joanna
A1 Gulley, James L
A1 Calvo, Katherine R
A1 Lai, Catherine
A1 Hourigan, Christopher S
YR 2022
UL http://jitc.bmj.com/content/10/1/e003392.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.